Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Analysis of clinical characteristics of Takayasu’s arteritis patients

CRISPR-Cas9 for disease resistance in salmon

Breastfeeding and cardiovascular diseases-are they linked?

Analysis of clinical characteristics of Takayasu’s arteritis patients
  • BiotechToday
  • World

Analysis of clinical characteristics of Takayasu’s arteritis patients

BioTech Today July 24, 2021July 23, 2021

Shrestha Dutta, Amity University Kolkata

About Takayasu’s arteritis (TA):

Takayasu’s arteritis (TA) is a chronic vasculitis of obscure etiology, predominantly influencing the aorta and its essential branches in ladies aged from 20 to 40 years. The assessed occurrence of TA in Europe and the USA is 0.4–2.6 per million individuals, while the pervasiveness is estimated to be more than 0.003% in Asian countries. Other than early-phase established manifestations, vascular complications like stroke, myocardial infarction, resistant hypertension, and cardiovascular breakdown can arise after arterial wall thickening, stenosis, occlusion, aneurysm, or thrombosis development because of growing inflammation. Subsequently, early inflammation control and vascular injury alleviation are the significant objectives of TA the board.

First-line treatment is glucocorticoids (GCs), with extra immunosuppressant and natural agents progressively directed for GC-safe TA or GC-saving help, while medical procedure or mediations are as yet important for end-organ/appendage ischemia improvement and the close 20% of TA patients without reaction to any prescriptions. Childhood Takayasu’s arteritis (c-TA) is described by damaging morbidity and mortality, and is seldom reported. In a recent study, Ying et al. aimed to examine the clinical course of c-TA and prognostic variables related to rehospitalization and events consisting of vascular complexities, flares, and passing. Childhood TA (c-TA), the most widely recognized huge vessel vasculitis in the pediatric population, has been concentrated in 17 accomplices of 445 c-TA cases (counting 24 Chinese patients) until now, with an unsure clinical profile however, the mortality rate is 27%.

Aim of the study:

Comprehensive information on administration and result prediction of c-TA are very inadequate. To resolve these issues, the current study aims to:

  • portray the clinical phenotypes, angiographic discoveries, and demonstrative calculation of c-TA; 
  •  sum up the therapeutic techniques and diagnosis for c-TA
  •  distinguish the indicators of c-TA results, including vascular intricacies, flares, all-cause death, and rehospitalization.

Result of this study:

An ambispective investigation of 101 c-TA patients fulfilling the American College of Rheumatology (ACR) rules and additionally the European League against Rheumatism (EULAR)/Pediatric Rheumatology International Trials Organization (PRINTO)/Pediatric Rheumatology European Society (PReS) rules was led from January 2002 to December 2017. Information on segment, clinical, research center, imaging, and remedial highlights were gathered. Occasion-free endurance, complication-free endurance, flare survival, rehospitalization-free endurance, and related prognostic elements were surveyed by Kaplan-Meier endurance curve and score examination.

This huge ambispective investigation of c-TA uncovers early mortality and morbidity, with 3% of patients passing on by the first year and around half suffering no less than an occasion or rehospitalization inside the initial 5 years after medication. Hypertension, renal artery contribution, and revascularization dependent on glucocorticoids, antihypertensive medications, and antiplatelet agents are the center clinical, imaging, and remedial highlights of c-TA with idealistic signs on the further diagnosis. Stroke, raised CRP, lower BMI level, and younger age at confirmation are, in any case, a free danger factor of helpless results. Further investigations are needed to develop a danger appraisal model of c-TA and its approval.

Reference:

  1. Ying, S., Sifan, W., Yujiao, W., Rongyi, C., Qingrong, H., Lili, M., Huiyong, C., & Lindi, J. (2021). Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension. Arthritis Research & Therapy, 23(1), 196. https://doi.org/10.1186/s13075-021-02579-8
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Shrestha Dutta is a 4th-year Biotechnology Engineering Student with a great interest in Genetics, Recombinant DNA Technology, and Immunology. She is a creative scientific writer in Bioxone with an inclination towards gaining knowledge regarding various sections of Biotechnology and engaging herself in various wet lab skills. She also has a review paper published in the journal IJSER.

Reference links:

  1. https://www.ijser.org/researchpaper/Unfaltering-boon-of-Nanotechnology-on-Plant-Growth.pdf
  2. https://bioxone.in/news/worldnews/therapy-for-congenital-myasthenia-a-destructive-neuromuscular-disorder/
  3. https://bioxone.in/news/indianews/first-cadaveric-liver-transplantation-in-india-by-hope-pump/
  4. https://bioxone.in/news/worldnews/nanodecoys-from-special-lung-cells-can-kill-sars-cov2/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged takayasu arteritis articles takayasu arteritis disease takayasu arteritis features takayasu arteritis flare takayasu arteritis review takayasu arteritis treatment Takayasu’s arteritis

2 thoughts on “Analysis of clinical characteristics of Takayasu’s arteritis patients”

  1. Pingback: PDBeCIF: For manipulating macromolecular Crystallographic Information File - BioXone
  2. Pingback: The first-ever CRISPR/Cas9 genome editing in marsupials - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Breastfeeding and cardiovascular diseases-are they linked?

BioTech Today July 24, 2021

Sarah Khatkhatay, SK Somaiya Vidhyadhar There is a reason why breast milk is known as “liquid gold”- it is an incredible substance that nourishes, adapts, and protects the baby against illness. It is one of the most fruitful ways to ensure child health and survival. Breastmilk proves to be an ideal food for infants as […]

breastfeeding

Related Post

  • BiotechToday
  • World

Understanding Allogeneic adipose-derived stem cell

bioxone March 22, 2021March 22, 2021

Souradip Mallick, National Institute of Technology, Rourkela An accident in any nuclear facility of the nuclear fuel cycle like a nuclear reactor leads to a large-scale release of radioactivity in the environment causing a great radiation exposure. The shock wave affects humans by rupturing eardrums or lungs. However, there are no fruitful, safe therapies for […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Engineered antibody: Potential cure to COVID – 19?

bioxone November 22, 2020November 22, 2020

Prama Ghosh, Amity University Kolkata The utilization of antibodies to battle human illness goes back to the 1890s and it is in practice even today. The blood plasma of patients who have recovered from COVID-19 contains antibodies against the SARS-CoV-2 virus which is called plasma therapy and used as a treatment for people with coronavirus […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

SGL: Hidden part in Bacteriophages could be a Protein Antibiotic

bioxone March 18, 2021March 18, 2021

Ayooshi Mitra, Amity University, Kolkata Antibiotic-resistant bacteria are becoming a greater threat to human health day by day, necessitating the development of new antibiotics. Bacteriophages and their potential as antibacterial agents to combat pathogenic bacteria have sparked renewed interest. This is largely due to the phage’s ability to cause a cellular breakdown in the bacterial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy